PTGER4
MOLECULAR TARGETprostaglandin E receptor 4
PTGER4 (prostaglandin E receptor 4) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PTGER4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Dinoprostone | 3.71 | 40 |
| 2 | Alprostadil | 2.48 | 11 |
| 3 | Dinoprost | 2.08 | 7 |
| 4 | bay 876 | 1.95 | 6 |
| 5 | Prostaglandin D2 | 1.61 | 4 |
| 6 | Epoprostenol | 0.69 | 1 |
| 7 | Metergoline | 0.69 | 1 |
| 8 | Misoprostol | 0.69 | 1 |
About PTGER4 as a Drug Target
PTGER4 (prostaglandin E receptor 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented PTGER4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PTGER4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.